The FDA announced acerbated approval of Enhertu for the treatment of breast cancer that is unable to be removed surgically and/or metastasized. It is also approved for patients with HER2-positive breast cancer who did not respond to two or more anti-HER2 therapies.
Related Articles
The post FDA Approves Enhertu for Advanced Cases of Breast Cancer appeared first on Latest Health & Medical News – Myhealthyclick.com.
